Aviwell's flagship product is Aneto™, an AI-powered microbiome discovery platform.
Hatch Blue media relations
The animal nutrition technology firm, Aviwell SAS, has successfully closed an €11 million Series A investment round, welcoming three new investors: Blue Revolution Fund (BRF), Blast.Club, and SWEN Capital Partners.
This financial support will enable the French company to advance native, nature-based biological solutions, focusing on the poultry and aquaculture markets. Elaia and MFS Investment Management were already among Aviwell’s existing shareholders and also participated in this funding round.
Aviwell's flagship product is Aneto™, an AI-powered microbiome discovery platform. This system is based on co-founder Rémy Burcelin's theory, which suggests that natural bacterial communities given early in life can have a long-lasting impact on animal growth, health, and resilience.
Aneto™ identifies specific molecular mechanisms and enables an efficient discovery process, reducing research and development timelines and costs while enabling faster commercialization.
"Aviwell sits at the intersection of two powerful market forces: rising global demand for animal protein, and the accelerating consumer shift toward natural, sustainable, antibiotic‑free production systems," explained Mouli RAMANI, the President and CEO of Aviwell.
In addition, Managing Partner at BRF, Georg Baunach, stated: "We are deeply impressed by Aviwell's scientific depth and technological precision. Aneto™ represents a new generation of microbiome innovation—one that captures the inherent complexity of biological systems."
Finally, the founder of Blast.Club., Anthony Bourbon noted: "We invested in Aviwell for one simple reason: they are revolutionizing the agri‑food industry. Aviwell uses AI and life sciences to naturally boost animal growth, without hormones or antibiotics, simply by working on the microbiota."